MICHAEL ABBOTT - 27 Mar 2023 Form 4 Insider Report for Columbia Care Inc. (CBSTF)

Role: Chairman, Director
Signature: /s/ David Sirolly as attorney-in-fact for Michael Abbott
Issuer symbol: CBSTF
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 29 Mar 2023, 21:28:31 UTC
Previous filing: 28 Dec 2022
Next filing: 07 Oct 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CBSTF	Common Shares	Options Exercise		+468,605	+62%		1,229,961	27 Mar 2023	Direct	F1, F2
transaction	CBSTF	Common Shares	Options Exercise		+319,523	+26%		1,549,484	27 Mar 2023	Direct	F1, F3
transaction	CBSTF	Common Shares	Options Exercise		+168,990	+11%		1,718,474	27 Mar 2023	Direct	F1, F4
transaction	CBSTF	Common Shares	Options Exercise		+51,239	+3%		1,769,713	27 Mar 2023	Direct	F1, F5
transaction	CBSTF	Common Shares	Options Exercise		+633,051	+36%		2,402,764	27 Mar 2023	Direct	F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CBSTF	Restricted Stock Units	Options Exercise	$0	-468,605	-100%	$0.000000^*	0	27 Mar 2023	Common Shares	468,605		Direct	F1, F2
transaction	CBSTF	Restricted Stock Units	Options Exercise	$0	-319,523	-100%	$0.000000^*	0	27 Mar 2023	Common Shares	319,523		Direct	F1, F3
transaction	CBSTF	Restricted Stock Units	Options Exercise	$0	-168,990	-100%	$0.000000^*	0	27 Mar 2023	Common Shares	168,990		Direct	F1, F4
transaction	CBSTF	Restricted Stock Units	Options Exercise	$0	-51,239	-100%	$0.000000^*	0	27 Mar 2023	Common Shares	51,239		Direct	F1, F5
transaction	CBSTF	Restricted Stock Units	Options Exercise	$0	-633,051	-100%	$0.000000^*	0	27 Mar 2023	Common Shares	633,051		Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2	The RSUs were granted on March 31, 2022, and vested 1/4 annually beginning March 31, 2023, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated as a result of a termination and release of claims agreement between the Issuer and the reporting person dated March 15, 2023 (the"Agreement").
F3	The RSUs were granted on March 23, 2021, and vested 1/4 annually beginning March 23, 2022, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.
F4	The RSUs were granted on March 31, 2020, and vested 1/4 annually beginning March 31, 2021, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.
F5	The RSUs were granted on September 30, 2019, and vested 1/4 annually beginning April 29, 2020, with settlement to occur as soon as practicable following the applicable vesting date. Vesting was accelerated pursuant to the Agreement.
F6	The performance stock units ("PSUs") were granted on March 31, 2020, and March 23, 2021. Each PSU represents a contingent right to receive one share of the Issuer's common stock. Vesting was accelerated pursuant to the Agreement.